DNA microarrays
- PMID: 15703470
- DOI: 10.1159/000083764
DNA microarrays
Abstract
Until recently, diagnostic and prognostic assessment of diseased tissues in a Pathology laboratory relied on histological and immunohistological studies. DNA microarray technology now allows the simultaneous analysis of up to thousands of different genes in histological or cytological specimens. Thus, the microarray techniques offer opportunities for the pathologist to obtain 'molecular signatures' of the state of activity of diseased cells in patient tissue samples, providing new information, such as the biological staging of tumors, a risk assessment of pre-malignant lesions, resistance to, and side effects of, treatment, molecular mechanisms in neurodegeneration and inflammation, and detection of micro-organisms. However, despite the great promise of this revolutionary technology, there are several issues that may undermine the power of the DNA microarray approach. After a short summary of the different forms of microarray and the contribution of this technology to understanding human disease, this short review focuses on the potential pitfalls and the important issues that must be considered when using a DNA microarray. Although this new approach shows great potential, the successful application of gene arrays to diagnostic and prognostic problems requires thoughtful interpretation and a strong correlation with other data, such as clinical, histopathological and immunohistochemical findings.
Copyright (c) 2005 S. Karger AG, Basel.
Similar articles
-
[DNA-chips in the diagnosis of hematological malignancies].Internist (Berl). 2006 Jan;47(1):39-46. doi: 10.1007/s00108-005-1526-2. Internist (Berl). 2006. PMID: 16247632 Review. German.
-
Dimension reduction-based penalized logistic regression for cancer classification using microarray data.IEEE/ACM Trans Comput Biol Bioinform. 2005 Apr-Jun;2(2):166-75. doi: 10.1109/TCBB.2005.22. IEEE/ACM Trans Comput Biol Bioinform. 2005. PMID: 17044181
-
Microarray based diagnosis profits from better documentation of gene expression signatures.PLoS Comput Biol. 2008 Feb;4(2):e22. doi: 10.1371/journal.pcbi.0040022. PLoS Comput Biol. 2008. PMID: 18282081 Free PMC article.
-
Independent component analysis-based penalized discriminant method for tumor classification using gene expression data.Bioinformatics. 2006 Aug 1;22(15):1855-62. doi: 10.1093/bioinformatics/btl190. Epub 2006 May 18. Bioinformatics. 2006. PMID: 16709589
-
Application of microarrays to the analysis of gene expression in cancer.Clin Chem. 2002 Aug;48(8):1170-7. Clin Chem. 2002. PMID: 12142369 Review.
Cited by
-
Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.Invest Ophthalmol Vis Sci. 2011 Oct 3;52(11):7807-16. doi: 10.1167/iovs.10-7063. Invest Ophthalmol Vis Sci. 2011. PMID: 21908583 Free PMC article.
-
Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice.Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2024-34. doi: 10.1167/iovs.09-3560. Epub 2009 Sep 8. Invest Ophthalmol Vis Sci. 2010. PMID: 19737878 Free PMC article.
-
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.Genes Immun. 2012 Feb;13(2):146-54. doi: 10.1038/gene.2011.66. Epub 2011 Sep 22. Genes Immun. 2012. PMID: 21938015 Free PMC article.
-
Gene expression changes in steroid-induced IOP elevation in bovine trabecular meshwork.Invest Ophthalmol Vis Sci. 2011 Nov 7;52(12):8636-45. doi: 10.1167/iovs.11-7563. Invest Ophthalmol Vis Sci. 2011. PMID: 21980000 Free PMC article.
-
Ovarian transcriptomes as a tool for a global approach of genes modulated by gonadotropic hormones in human ovarian granulosa cells.Endocrine. 2005 Apr;26(3):259-65. doi: 10.1385/endo:26:3:259. Endocrine. 2005. PMID: 16034180 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources